Stock screener

IBRX

Conviction 74HealthcareScan · Thu, Sep 24, 2026

ImmunityBio, Inc. (IBRX) closed at $8.64 (+0.12%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 56, RS Rating 99, -25.2% from its 52-week high, +327.7% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

IBRX$8.64+0.12%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 12.09M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +100.00%· 2 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
ImmunityBio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.immunitybio.com ↗
Price8.64
Change+0.12%
Gap-1.51%
Rel volume1.35×
Avg volume10.77M
Avg $ vol89.97M
SMA 208.24
SMA 507.81
SMA 2007.00
Price vs 50+10.56%
Price vs 200+23.44%
MA stackbullish
50/200 cross—
Supertrendup · 7.26
RSI (14)56
MACD hist0.06
MACD crossbull · 5d
Stoch %K / %D54 / 66
ADX (14)32
+DI / −DI28 / 12
RSI divergence—
MACD divergence—
ATR %6.02%
ADR %5.73%
52w high11.55
52w low1.98
From 52w high-25.19%
Above 52w low+336.36%
New 52w highNo
SqueezeFired
Bollinger width17.19%
%B0.78
Donchian pos54.35%
Donchian high9.48
Donchian low7.64
AVWAP (52w high)8.12
vs AVWAP high+6.42%
AVWAP (52w low)6.93
vs AVWAP low+24.64%
OBV trendUp
Chaikin MF (20)0.07
Today vs 20d1.35×
Avg vol (14d)12.09M
Avg vol (20d)10.77M
Avg $ vol (20d)89.97M
Market cap9.16B
RS Rating99 / 99
RS 3m (vs SPY)+6.42%
RS 6m (vs SPY)-9.75%
RS line new highNo
Trend template6/8
Technical rank86.6
1 week+2.13%
1 month+5.49%
3 months+10.91%
6 months+7.06%
1 year+233.59%
YTD+327.72%
P/E-26.06
P/B-8.75
P/S80.83
P/FCF-29.66
EPS-0.3800
Div yield—
ROE33.57%
ROA-55.91%
Debt/Eq-0.00
Current5.72
EV/EBITDA-37.76
Gross margin—
Net margin-310.18%
Rev growth668.31%
EPS growth15.03%
Price target13.00
Target upside50.46%
Analyst ratingBuy
Institutional22.25%
Ent. value9.08B
Revenue51.24M
Net income-230.38M
Gross profit—
Free cash flow-308.78M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out1.05B
Employees691
ListedWed, Mar 10, 2021
Free float368.17M
Float %35.8%
Short interest125.64M
Days to cover14.8d
Short volume64.2%
Squeeze score86 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.08 vs −$0.09
Last surprise+11.1% beat
Setup gradeB
Conviction74 / 100
Pattern quality—
Tech rank86.6 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance9.12
Support7.07
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IBRX

All disclosures →
No recent disclosed trades by Congress in IBRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IBRX · open-market 1 sell

InsiderSideShares
Wendel Bruce
Director · Stock Option (right to buy) · 2026-06-09
Grant65.6K
BLASZYK MICHAEL D
Director · Stock Option (right to buy) · 2026-06-09
Grant65.6K
Cohen Cheryl
Director · Stock Option (right to buy) · 2026-06-09
Grant65.6K
Clark Wesley
Director · Stock Option (right to buy) · 2026-06-09
Grant65.6K
Selecky Christobel
Director · Stock Option (right to buy) · 2026-06-09
Grant65.6K
MAXWELL LINDA
Director · Stock Option (right to buy) · 2026-06-09
Grant65.6K
Simon Barry J.
Director · Common Stock · 2026-06-04
Sell23.03K

SEC filings

EDGAR filings in IBRX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.